Entecavir With or Without Pegylated Interferon -2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B

• Status: NOT_YET_RECRUITING
• Trial end date: 2030-12-31

Summary

This study aims to evaluate the efficacy and safety of entecavir monotherapy versus sequential entecavir plus pegylated interferon -2b in achieving functional cure in immune-active, HBeAg-positive children aged 3-6 years with chronic hepatitis B.

• Phase: PHASE4

Details

• Lead Sponsor: Qing-Lei Zeng
• Collaborators: Henan Provincial People's Hospital; Luohe Central Hospital; Luoyang Central Hospital; Nanyang Central Hospital; Sanmenxia Central Hospital; Shangcheng County People's Hospital; The First Affiliated Hospital of Henan Medical University; The First Affiliated Hospital of Henan Polytechnic University; The Sixth People's Hospital of Zhengzhou; The Third Affiliated Hospital of Henan Medical University; Weishi County People's Hospital; Xuchang Central Hospital; Yongcheng People's Hospital
• Treatments: entecavir